Report copyright - Galectin Therapeutics, Inc. (NASDAQ: GALT) is a leading ......Jul 31, 2018 · drugs targeting NASH and cirrhosis is projected to be $35 - $40B worldwide in 2025.3 A key indicator
Please pass captcha verification before submit form
Please pass captcha verification before submit form